ZZ Biotech, LLC   Report issue

For profit Phase 1 Phase 3
Founded: Houston TX United States (2006)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2012
NCT01660230
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

ZZ Biotech, LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

3k3a-apc (4 trials)

Drugs in Phase 1 Trials (1)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 2)

Ischemia (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 2